| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -2.3e-05 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -7.4e-05 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |